Evidence map›Paper›PMID 41740951›Full record

ArticleAnalytical chemistry2026

Open-Source Benchtop Magnetophotometer for Characterizing the Magnetic Susceptibility of Suspended Nanoparticles.

Alexis Scholtz, Jack G Paulson, Armando D Urbina, Fakhar Singhera, Victoria Nuñez, Andrea M Armani

Abstract read
In one paragraph

Article in Analytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alexis ScholtzAlfred E. Mann Department of Biomedical Engineering, University of Southern California, Los Angeles, California 90089, United States.ORCID 0000-0001-6275-0622
Jack G PaulsonEllison Medical Institute, Los Angeles, California 90064, United States.ORCID 0000-0002-1889-0756
Armando D UrbinaEllison Medical Institute, Los Angeles, California 90064, United States.ORCID 0000-0003-3036-4991
Fakhar SingheraEllison Medical Institute, Los Angeles, California 90064, United States.ORCID 0009-0000-8681-5769
Victoria NuñezThomas Lord Department of Computer Science, University of Southern California, Los Angeles, California 90089, United States.
Andrea M ArmaniAlfred E. Mann Department of Biomedical Engineering, University of Southern California, Los Angeles, California 90089, United States.ORCID 0000-0001-9890-5104

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Magnetic nanoparticles (MNPs) form the foundation of many technologies, frequently serving to purify proteins or cells from a biological sample or to remove environmental contaminants. Their success relies on their magnetic response, which allows them to be easily controlled in a liquid or solution. Therefore, the magnetic susceptibility provides one metric for assessing the suitability of a MNP for a given application. Unfortunately, conventional methods for measuring the magnetic susceptibility relies on instrumentation that characterizes the MNPs as a dry powder. Because MNPs are typically used in suspension, the measured value may be different from their behavior in suspension, thus providing inaccurate readings. Here, we present the design and validation of a magnetophotometer (MAP), an instrument that characterizes the effective magnetic susceptibility of suspended MNPs via differential optical spectroscopy, providing a more relevant measure of MNPs' magnetic properties. As part of this work, we developed a mathematical model to calculate the effective magnetic susceptibility from the MAP data and validated the model using measurements with a range of magnetic nanoparticles, including particles with different material compositions, sizes, architectures, and surface coatings. Finally, we demonstrate that MAP testing is nondestructive by successfully characterizing bioconjugated particles without damaging the bioactivity of the surface bioconjugation, providing a path for in-line quality control assessment.

Identifiers

PMID41740951
PMCPMC12980482

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.